PRESS RELEASE published on 05/31/2024 at 13:30, 2 years 1 month ago FSD Pharma, Inc. Wins Petition to Confirm Arbitration Awards Entered Against Dr. Raza Bokhari Totaling Over $3 Million CAD, Plus Interest FSD Pharma Inc. confirms arbitration awards against former CEO Dr. Raza Bokhari. United States District Court grants final judgment for monetary damages. Company focuses on biopharmaceutical solutions for neurodegenerative disorders FSD Pharma Inc. Arbitration Awards Neurodegenerative Disorders United States District Court Biopharmaceutical Solutions
BRIEF published on 05/28/2024 at 14:05, 2 years 1 month ago FSD Pharma soumet un protocole d'essai clinique pour Unbuzzd™ dans le traitement de l'intoxication alcoolique aiguë FSD Pharma Essai Clinique Unbuzzd™ Intoxication Alcoolique Essai METAL-2
BRIEF published on 05/28/2024 at 14:05, 2 years 1 month ago FSD Pharma Submits Clinical Trial Protocol for Unbuzzd™ in Acute Alcohol Intoxication FSD Pharma Clinical Trial Unbuzzd™ Alcohol Intoxication METAL-2 Trial
PRESS RELEASE published on 05/28/2024 at 14:00, 2 years 1 month ago FSD Pharma Submits a Clinical Trial Protocol to Study the Safety and Efficacy of Unbuzzd(TM) in Acute Alcohol Intoxication FSD Pharma submits clinical trial protocol for Unbuzzd(TM) to assess safety and efficacy in a crossover design trial to study effects on alcohol intoxication. Dr. Andrzej Chruscinski comments on the milestone reached FSD Pharma Unbuzzd(TM) Alcohol Intoxication Clinical Trial Protocol Dr. Andrzej Chruscinski
BRIEF published on 05/24/2024 at 20:39, 2 years 1 month ago FSD Pharma annonce un accord de relations avec les investisseurs avec IR Agency LLC Biopharmaceutique FSD Pharma Relations Avec Les Investisseurs Agence RI Psychéeutiques Lucides
BRIEF published on 05/24/2024 at 20:39, 2 years 1 month ago FSD Pharma Announces Investor Relations Agreement with IR Agency LLC Investor Relations FSD Pharma Biopharmaceutical IR Agency Lucid Psycheceuticals
PRESS RELEASE published on 05/24/2024 at 20:34, 2 years 1 month ago FSD Pharma Provides Corporate Update FSD Pharma Inc. enters investor relations services agreement with IR Agency LLC, focusing on communicating information to the financial community. Company building innovative biotech solutions Investor Relations FSD Pharma Inc. Biopharmaceutical Innovative Assets IR Agency LLC
BRIEF published on 05/16/2024 at 14:05, 2 years 1 month ago FSD Pharma Announces New Packaging for Unbuzzd™ Beverage FSD Pharma Beverage Industry Unbuzzd New Packaging Responsible Drinking
BRIEF published on 05/16/2024 at 14:05, 2 years 1 month ago FSD Pharma annonce un nouvel emballage pour la boisson Unbuzzd™ FSD Pharma L'industrie Des Boissons Consommation Responsable Unbuzzd Nouvel Emballage
PRESS RELEASE published on 05/16/2024 at 14:00, 2 years 1 month ago FSD Pharma Provides Update on Celly Nu's New Packaging for unbuzzd(TM) FSD Pharma Inc. announces new packaging and logo for unbuzzd™ beverage product in collaboration with Celly Nutrition Corp. and Six+One, set to launch this summer, targeting alcohol metabolizing and promoting alertness FSD Pharma Inc. Celly Nutrition Corp. Unbuzzd Six+One Packaging Logo
Published on 07/14/2026 at 01:45, 5 hours 7 minutes ago Arctic Fox Lithium Approved for Trading on the OTCQB Venture Market and Announces DTC Eligibility
Published on 07/14/2026 at 00:01, 6 hours 51 minutes ago Captor Capital Announces Delay in its Annual Filings
Published on 07/13/2026 at 23:10, 7 hours 42 minutes ago Galaxy Ventures Inc. Announces Director Resignation
Published on 07/13/2026 at 21:35, 9 hours 17 minutes ago ATHA Energy Announces Corporate Activities Update
Published on 07/13/2026 at 20:00, 10 hours 52 minutes ago IBC Announces Share-Based Compensation to Directors
Published on 07/14/2026 at 06:30, 22 minutes ago Formycon AG and OneSource Specialty Pharma announce strategic Manufacturing Partnership for Biosimilars
Published on 07/14/2026 at 04:45, 2 hours 7 minutes ago Asia’s Debut of LEAP East in HKCEC Marks Hong Kong’s Largest Inaugural Tech Summit
Published on 07/13/2026 at 22:30, 8 hours 22 minutes ago Half-year 2026 Results Media and Investor Conference Call and Webcast
Published on 07/13/2026 at 21:20, 9 hours 32 minutes ago Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook
Published on 07/13/2026 at 21:17, 9 hours 34 minutes ago EQS-Adhoc: Ad hoc: Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook
Published on 07/13/2026 at 18:00, 12 hours 52 minutes ago CP Icade - Icade reprend 100% de la propriété de la Tour Eqho à la Défense
Published on 07/13/2026 at 18:00, 12 hours 52 minutes ago PR Icade - Icade regains full ownership of the Eqho Tower in La Défense
Published on 07/13/2026 at 18:00, 12 hours 52 minutes ago THERMADOR GROUPE : publication du chiffre d'affaires semestriel 2026